INS and type 1 diabetes mellitus: A battery of literature supports the effective and safe use of IDeg over other basal insulin analogs in T1DM adult population in terms of significant glycemic control with a lower risk of hypoglycemia, nocturnal hypoglycemia, dose requirement and higher flexibility [12–14].